Ying Du
Chief Executive Officer at ZAI LAB LIMITED
Net worth: 2 M $ as of 2024-03-30
Profile
Founder of Zai Lab Ltd., Hutchison MediPharma Ltd. and Zai Venture Partners, Ying Du is an entrepreneur who occupies the position of Chairman & Chief Executive Officer at Zai Lab Ltd. and General Partner at Zai Venture Partners (a subsidiary of Zai Lab Ltd.). Dr. Du is also on the board of Eden Biologics, Inc. In the past Dr. Du occupied the position of Chief Executive Officer for Hutchison MediPharma Ltd., Chief Scientific Officer at Hutchison China MediTech Ltd., Executive Vice President-Healthcare Investment at Hutchison Whampoa (China) Ltd. and Venture Partner at Sequoia Capital China Advisors (Hong Kong) Ltd. Ying Du received a doctorate from the University of Cincinnati (Ohio) and an undergraduate degree from Jilin University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ZAI LAB LTD.
0.11% | 2024-04-02 | 1,107,972 ( 0.11% ) | 2 M $ | 2024-03-30 |
Latest news about Ying Du
Ying Du active positions
| Companies | Position | Start |
|---|---|---|
| ZAI LAB LIMITED | Chief Executive Officer | 2014-03-31 |
| JHL BIOTECH, INC. | Director/Board Member | 2012-12-16 |
Zai Venture Partners
 Zai Venture Partners Investment ManagersFinance Zai Venture Partner is a venture capital investment firm. The firm is headquartered in Cayman Islands. It is founded by Ying Samantha Du in 2017. | Founder | 2016-12-31 |
Former positions of Ying Du
| Companies | Position | End |
|---|---|---|
Hongshan
 Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | Private Equity Investor | - |
Hutchison Whampoa (China) Ltd.
 Hutchison Whampoa (China) Ltd. Financial ConglomeratesFinance Part of CK Hutchison Holdings Ltd., Hutchison Whampoa (China) Ltd. is a Chinese company that provides investment services. The private company is based in Hong Kong, Hong Kong. Chi Keung To has been the CEO of the company since 1980. | Corporate Officer/Principal | - |
| HUTCHMED (CHINA) LIMITED | Chief Tech/Sci/R&D Officer | - |
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Chief Executive Officer | - |
Training of Ying Du
| University of Cincinnati (Ohio) | Doctorate Degree |
| Jilin University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| HUTCHMED (CHINA) LIMITED | Health Technology |
| ZAI LAB LIMITED | Health Technology |
| Private companies | 5 |
|---|---|
Hutchison Whampoa (China) Ltd.
Hutchison Whampoa (China) Ltd. Financial ConglomeratesFinance Part of CK Hutchison Holdings Ltd., Hutchison Whampoa (China) Ltd. is a Chinese company that provides investment services. The private company is based in Hong Kong, Hong Kong. Chi Keung To has been the CEO of the company since 1980. | Finance |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | Finance |
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
Eden Biologics, Inc.
 Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |
Zai Venture Partners
Zai Venture Partners Investment ManagersFinance Zai Venture Partner is a venture capital investment firm. The firm is headquartered in Cayman Islands. It is founded by Ying Samantha Du in 2017. | Finance |
- Stock Market
- Insiders
- Ying Du
